Alfonso G. Zulueta
SVP& Pres., Emerging Markets, Eli Lilly and Company.
Companies
- CTS CORPBoard member Apr 18, 2018 to now1
- Calidi Biotherapeutics, Inc.Board member Jan 4, 2024 to Jan 4, 20242
- Syneos Health, Inc.Board member Jan 20, 2022 to Sep 28, 20233
- Amarin CorporationBoard member May 20, 2022 to Jun 29, 20224
- Eli Lilly and CompanySVP& Pres., Emerging Markets Jan 10, 2014 to Feb 10, 20215
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY61,614 shares6$78.4M at $1,272.75Feb 10, 2021- CTS CORP CTS35,913 shares7$2.0M at $55.56Nov 6, 2025
- Calidi Biotherapeutics, Inc. CLDI133,301 shares8$102.6K at $0.77Dec 21, 2023
- Syneos Health, Inc.0 shares9Sep 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 6, 2025Granted 3,500 shares of CTS CORP7
- Nov 7, 2024Granted 2,400 shares of CTS CORP10
- Dec 21, 2023Granted 5,644 shares at $1.80 of Calidi Biotherapeutics, Inc.8
- Nov 2, 2023Granted 3,600 shares of CTS CORP11
- Sep 28, 2023Returned to company 4,863 shares of Syneos Health, Inc.9
- Sep 28, 2023Returned to company 3,493 shares at $43.00 of Syneos Health, Inc.9
- May 25, 2023Granted 4,863 shares of Syneos Health, Inc.12
- Nov 10, 2022Granted 3,100 shares of CTS CORP13
- May 25, 2022Granted 2,839 shares of Syneos Health, Inc.14
- Jan 18, 2022Granted 654 shares of Syneos Health, Inc.15
- Nov 4, 2021Granted 3,600 shares at $36.69 of CTS CORP16
- Feb 8, 2021Granted 29,037 shares at $205.77 of Eli Lilly and Company6
- Feb 1, 2021Shares withheld for tax 7,490 shares at $207.97 of Eli Lilly and Company17
- Feb 1, 2021Exercised options 16,754 shares of Eli Lilly and Company17
- Jul 9, 2020Sold 11,000 shares at $170.00 of Eli Lilly and Company18
- Jun 16, 2020Sold 10,000 shares at $165.00 of Eli Lilly and Company19
- Jun 16, 2020Sold 7,000 shares at $160.00 of Eli Lilly and Company19
- Jun 5, 2020Sold 10,000 shares at $150.00 of Eli Lilly and Company20
- Feb 11, 2020Granted 18,322 shares of Eli Lilly and Company21
- Feb 1, 2020Shares withheld for tax 7,299 shares at $139.64 of Eli Lilly and Company22
- Feb 1, 2020Exercised options 16,317 shares of Eli Lilly and Company22
- Dec 6, 2019Sold 4,500 shares at $120.00 of Eli Lilly and Company23
- Sep 20, 2019Sold 4,500 shares at $117.00 of Eli Lilly and Company24
- Sep 3, 2019Sold 4,500 shares at $112.54 of Eli Lilly and Company25
- Sep 3, 2019Sold 3,808 shares at $113.69 of Eli Lilly and Company25
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Jul 9, 2020 | LLY | Sale | $1.9M | +651.9% | −506.4% | −2.6% |
| Jun 16, 2020 | LLY | Sale | $2.8M | +664.5% | −517.9% | +0.0% |
| Jun 5, 2020 | LLY | Sale | $1.5M | +738.8% | −597.1% | −16.9% |
| Dec 6, 2019 | LLY | Sale | $540.0K | +946.1% | −801.0% | −6.0% |
| Sep 20, 2019 | LLY | Sale | $526.5K | +977.5% | −818.7% | −20.5% |
| Sep 3, 2019 | LLY | Sale | $4.4M | +998.3% | −832.8% | −8.2% |
| Apr 12, 2019 | LLY | Sale | $1.2M | +917.1% | −751.1% | −22.4% |
| Jan 31, 2019 | LLY | Sale | $480.0K | +944.2% | −758.3% | +2.7% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCTS CORP, Board member
- 2
- 3SEC EDGARSyneos Health, Inc., Board member
- 4SEC EDGARAmarin Corporation, Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Nov 8, 2024
- 11SEC EDGARForm 4 filed Nov 6, 2023
- 12SEC EDGARForm 4 filed May 30, 2023
- 13SEC EDGARForm 4 filed Nov 14, 2022
- 14SEC EDGARForm 4 filed May 27, 2022
- 15SEC EDGARForm 4 filed Jan 20, 2022
- 16SEC EDGARForm 4 filed Nov 5, 2021
- 17SEC EDGARForm 4 filed Feb 3, 2021
- 18SEC EDGARForm 4 filed Jul 13, 2020
- 19SEC EDGARForm 4 filed Jun 18, 2020
- 20SEC EDGARForm 4 filed Jun 9, 2020
- 21SEC EDGARForm 4 filed Feb 13, 2020
- 22SEC EDGARForm 4 filed Feb 4, 2020
- 23SEC EDGARForm 4 filed Dec 9, 2019
- 24SEC EDGARForm 4 filed Sep 23, 2019
- 25SEC EDGARForm 4 filed Sep 9, 2019